AnvilCore Research
Mitoprime research material is available in 1 format. Select a tab to review the available strength.
Technical research description
Mitoprime combines NAD+, the mitochondrial-derived peptide MOTS-C, and 5-Amino-1MQ, a small-molecule NNMT inhibitor. Each component has a distinct metabolic research rationale, but published studies have not established the behavior, stability, or combined biological effect of the premixed formulation.
Mitoprime combines NAD+, the mitochondrial-derived peptide MOTS-C, and 5-Amino-1MQ, a small-molecule NNMT inhibitor. Each component has a distinct metabolic research rationale, but published studies have not established the behavior, stability, or combined biological effect of the premixed formulation.
Component information
NAD+: C₂₁H₂₇N₇O₁₄P₂
MOTS-C: Met — Arg — Trp — Gln — Glu — Met — Gly — Tyr — Ile — Phe — Tyr — Pro — Arg — Lys — Leu — Arg
5-Amino-1MQ: C₁₀H₁₁IN₂
MOTS-C: Met — Arg — Trp — Gln — Glu — Met — Gly — Tyr — Ile — Phe — Tyr — Pro — Arg — Lys — Leu — Arg
5-Amino-1MQ: C₁₀H₁₁IN₂
Mixed nucleotide-coenzyme, peptide, and small-molecule research blend.
Mitoprime — 120 mg
- Strength
- 120 mg
- Format
- Powder
- Retail price (USD)
- $104.00
Adds Mitoprime — 120 mg to your cart. Research and laboratory use only.
Research use only. Not for human consumption or clinical, diagnostic, or therapeutic use.